Mounjaro

The Hi Doctor consultation plan is €25 every 28 days at every dose. The medicine itself is paid at the pharmacy; its price depends on the country, the dose and whether your health system covers it.

In the SURMOUNT-1 trial, adults without diabetes lost on average 15.0% (5 mg), 19.5% (10 mg) and 20.9% (15 mg) of their body weight over 72 weeks, versus 3.1% on placebo. Results vary from person to person.

Take it as soon as possible within 4 days (96 hours) of the missed dose. If more than 4 days have passed, skip it and take the next dose on your usual day.

Yes, a doctor can review a switch. Tell us in the questionnaire which medicine and dose you use now, and when you took your last dose.

Nausea, diarrhoea, vomiting, constipation and reduced appetite, usually mild to moderate and most frequent while the dose is being increased.

Tirzepatide delays stomach emptying and can affect the absorption of oral medicines. Tell your doctor which contraceptive you use so they can review the current product information and explain how to stay protected.

Tirzepatide is a dual receptor agonist (GLP-1 and GIP) which, in trials, shows larger average weight loss than mono-agonist GLP-1s in adults with obesity.

Not necessarily. It is a chronic treatment while it is beneficial and safe: the doctor reviews response every 3 months and decides with you whether to continue, adjust or stop. Discontinuation must be gradual and paired with a maintenance plan.

History of pancreatitis, gallbladder issues, family history of medullary thyroid cancer, pregnancy or plans to conceive, and current medication. Recent labs are also reviewed if provided.

Quarterly medical review through the private in-app chat, dose adjustments if side effects arise, and a new electronic prescription valid in any EU pharmacy when applicable.

Yes. Tirzepatide is the active ingredient, and Mounjaro is the brand name it is sold under in the European Union. In the United States the same molecule is also sold as Zepbound for weight management, but Zepbound is not authorised in the EU, so an EU prescription for tirzepatide will be written for Mounjaro. The European Medicines Agency authorised Mounjaro on 15 September 2022, and its licence now covers both type 2 diabetes and weight management in adults who meet the BMI criteria.

Weight tends to come back. In SURMOUNT-4, adults who had already lost a mean of 20.9% over a 36-week lead-in were randomly assigned either to keep taking tirzepatide or to switch to placebo. Between week 36 and week 88 the continued group changed by a further -5.5%, while the placebo group regained 14.0%. At week 88, 89.5% of the continued group had kept at least 80% of the weight lost during the lead-in, compared with 16.6% of the placebo group. Stopping is a decision to make with your prescriber.

No. The product information lists 5 mg, 10 mg and 15 mg as the recommended maintenance doses, so 5 mg and 10 mg are licensed end points in their own right and not only steps on the way up. In SURMOUNT-1 the 5 mg group had a mean body-weight change of -15.0% at 72 weeks, the 10 mg group -19.5% and the 15 mg group -20.9%. Gastrointestinal side effects were also more frequent at higher doses. Your prescriber decides where to stop, based on how you respond and how well you tolerate each step.

Write to your doctor in the private chat in your account: describe what you notice and when it started. The doctor can adjust the plan, pause it or suggest another option. If you have severe symptoms such as difficulty breathing, swelling of the face or chest pain, call 112 or go to an emergency department straight away.

It depends on what you take. List every medicine, supplement and herbal product in the questionnaire, including ones you use only occasionally. The doctor checks for interactions before prescribing, and your pharmacist checks again when you collect Mounjaro.

The doctor can consider another weight-management medicine authorised in the EU, or a plan built on nutrition and activity alone. Some people are better served by an in-person obesity clinic or by their own doctor, and the doctor explains why when that is the case.

Before each renewal the doctor reviews your weight, side effects and how you feel, and decides whether to continue, change the dose or stop. Changes are never automatic. You can also write in the private chat between reviews.

Yes. Hi-Doctor runs 100 % online across the EU, so if you live in Madrid you can fill in the questionnaire and receive the medical review without travelling. The electronic prescription issued by the licensed doctor is valid in any EU pharmacy under Directive 2011/24/EU; in Spain it is dispensed directly from the prescription QR.

Adults with BMI ≥ 30, or ≥ 27 with comorbidities (hypertension, type-2 diabetes, dyslipidaemia). The doctor reviews your history, current medication and goals before proposing any treatment. It is not a cosmetic programme.

The private electronic prescription (Receta Médica Privada Electrónica) is issued by a licensed doctor in Spain. It is a PDF carrying every field required by EU Directive 2011/24/EU (patient, prescriber with country of registration, active ingredient, dose), which makes it legally recognised across all 27 EU member states. In Spanish pharmacies it is dispensed from the QR; outside Spain, the pharmacist dispenses the locally marketed equivalent of the same active ingredient.

1) Fill in an online medical questionnaire in about 4 minutes. 2) The plan is €25/month for weight loss or €15/month (billed €45 every 90 days) for hair growth; sexual health is €35 per consultation and a skin consultation is €40. 3) An EU-licensed doctor reviews your case and, if appropriate, issues an electronic prescription. 4) Collect it at any EU pharmacy. If the review is not approved, the applicable fee is refunded in full.

The plan is €25/month for weight loss or €15/month (billed €45 every 90 days) for hair growth; a one-off sexual-health consultation is €35 and a skin consultation covering acne, rosacea, melasma and ageing skin is €40. Each includes a licensed doctor's review and an electronic prescription if approved. If the review is not approved, the applicable fee is refunded in full. Medication is paid for separately at the pharmacy at the price it sets.